GlassScriptPhysician profile
Kevin M Klein
NPI 1336199793
$614.59
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $59.52 · 2021: $16.41 · 2022: $159.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $236.45 | 2019-2022 | |
| Eisai INC. | $122.12 | 2019 | |
| Sunovion Pharmaceuticals INC. | $119.41 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $59.52 | 2020 | |
| Supernus Pharmaceuticals, INC. | $34.67 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $16.41 | 2021 | |
| Livanova USA, INC. | $13.85 | 2022 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.